Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-10

Clinical Trial Update: Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis [NA]

View source ↗

Summary

This clinical trial update indicates that a study evaluating proactive therapeutic drug monitoring to optimize adalimumab therapy in rheumatoid arthritis has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Boston Medical Center | Conditions: Rheumatoid Arthritis | NA | Status: TERMINATED